OPDP Issues Final Guidance on Best Practices for Presenting

OPDP Issues Final Guidance on Best Practices for Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements | Foley Hoag LLP

On June 27, 2023, the Food and Drug Administration’s ("FDA") Office of Prescription Drug Promotion ("OPDP") published a final guidance (the "Final Guidance") on Presenting Quantitative...

Related Keywords

, Office Of Prescription Drug Promotion , Drug Administration , Foley Hoag , Final Guidance , Prescription Drug Promotion , Presenting Quantitative Efficacy , Risk Information , Promotional Labeling , Federal Trade Commission ,